Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14328
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPingaew R.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:34:12Z-
dc.date.available2021-04-05T03:34:12Z-
dc.date.issued2012
dc.identifier.issn2536269
dc.identifier.other2-s2.0-84864915962
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14328-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84864915962&doi=10.1007%2fs12272-012-0601-1&partnerID=40&md5=cd874f5e13565eacb3e914a762be1583
dc.description.abstractTungstosilicic acid hydrate was employed as an efficient catalyst for the synthesis of bisindolylmethanes 4 using the Friedel-Crafts reaction of N-sulfonyl tryptamine 5 with various aromatic aldehydes, except 3-formylindole. In the excluding case, tris-indolylmethane 7 was formed via a sequential addition-elimination-addition process. The bioactivity test revealed that the phenolic hydroxyl group plays an important role in cytotoxicity; it demonstrated that ortho- and para-hydroxy bis-indolylmethane (BIM) analogs (4b and 4d) displayed cytotoxic potency toward HepG2 (human hepatocellular liver carcinoma cell line) and MOLT-3 (human lymphoblastic leukemia cell line) cancer cell lines. Significantly, both analogs showed slightly higher inhibitory efficacy than the control drug, etoposide, in HepG2 cells, and the analog 4d exhibited the most potent activity against MOLT-3 cell lines, with an IC50 value of 1.62 μg/mL.
dc.subjectantineoplastic agent
dc.subjectbis indolylmethane
dc.subjectcarboline derivative
dc.subjectdoxorubicin
dc.subjectetoposide
dc.subjectsilicic acid
dc.subjecttris indolylmethane
dc.subjecttungstosilicic acid hydrate
dc.subjectunclassified drug
dc.subjectaddition reaction
dc.subjectarticle
dc.subjectcell strain HepG2
dc.subjectcell survival
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjectelimination reaction
dc.subjectFriedel Crafts reaction
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC 50
dc.subjectAntineoplastic Agents
dc.subjectCarbolines
dc.subjectCell Survival
dc.subjectDose-Response Relationship, Drug
dc.subjectEtoposide
dc.subjectHep G2 Cells
dc.subjectHumans
dc.subjectIndoles
dc.subjectInhibitory Concentration 50
dc.subjectMolecular Structure
dc.titleSynthesis and cytotoxicity of novel 2,2'-Bis- and 2,2',2''-Tris-indolyl- methanes-based bengacarboline analogs
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationArchives of Pharmacal Research. Vol 35, No.6 (2012), p.949-954
dc.identifier.doi10.1007/s12272-012-0601-1
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.